Atlas Trials

Mechanistic Assessment of Norepinephrine Therapy vs. Angiotensin-II in Septic Shock

Clinical trial NCT06746753 · NOT_YET_RECRUITING

Trial details

NCT number
NCT06746753
Sponsor
Wake Forest University Health Sciences
Status
NOT_YET_RECRUITING
Phase
Phase 4
Study type
INTERVENTIONAL
Septic Shock
Start date
2026-09-01
Primary completion
2028-09-30
Enrollment
78

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.